All News

As November is National Caregivers Month, it seems appropriate to honor those who stand by us during life's most challenging moments.

The recent World Health Organization announcement classifying processed meat as a Group 1 carcinogen isn't really news. It's just common sense.

The designation, which will expedite the development and review of Keytruda in this space, was based on findings from an ongoing phase 2 study.

How you make a decision is sometimes as important as the decision you make.

Something in the way she moves ...

With the flip of a coin, I became one with logic instead of reacting emotionally.

Some say I'm a lucky person. I say it's who I am.

This video was produced by The Esophageal Cancer Awareness Association. It features the compelling stories of EC survivors: former US Congresswoman Ellen Tauscher, Jeff Thomas and Roger Tunsley.

This video was produced by The Esophageal Cancer Awareness Association. It features the compelling stories of EC survivors: Brian Galgay and Karen Kent.

An academically trained skeptic, this single project has turned me into a raving optimist.

A glimpse into stereotactic radiosurgery for lung cancer spread to the brain.

XRAYS aims to be "a reliable resource designed to help young breast cancer survivors and high-risk women navigate through breast cancer research related news and information."

I will be out on the street in New York City on November 1 to cheer on James Blake.

The approval is based on results from the phase 3 EORTC 18071 trial, in which adjuvant Yervoy reduced the risk of recurrence by 25 percent versus placebo.

Lack of insurance is one of the greatest barriers to access to health care.

The idea of trading in a primary care physician for an oncologist still brings a knot to my stomach. I'm well aware that the biannual blood tests and annual X-rays have one purpose: scanning for the return of the monster.

Kevin realizes that the trauma caused by losing space shuttles turns out to feel a lot like finding out you have cancer — only lonelier.

The approval was based on results from the phase 3 OPTiM study in which Imlygic significantly extended durable response rates compared with GM-CSF.

Your loved ones and an army of health care providers can help you win.

It is a woman's choice to advocate for themselves, while assessing the risk for these types of tests that are available.

Facing chronic illness can change the way you see the world. It can also change the way the world sees you and how you interact with it.

Cancer is a terrifying word. Here's how to let the patient know the news is bad.

"I think I can, I think I can," says a two-time cancer survivor.

The approval is based on results from the phase 3 ET743-SAR-3007 trial.

To gain insight into the updated ACS breast screening guidelines, CURE spoke with our editor-in-chief, Debu Tripathy.